
簡要描述:Acipimox 51037-30-0Acipimox is a niacin derivative used as a hypolipidemic agent.
產(chǎn)品分類
Product Category詳細介紹
| 品牌 | absin | CAS | 51037-30-0 |
|---|---|---|---|
| 分子式 | C6H6N2O3 | 純度 | 99% |
| 分子量 | 154.13 | 貨號 | abs47027529 |
| 規(guī)格 | 25mg | 供貨周期 | 現(xiàn)貨 |
| 主要用途 | used as a hypolipidemic agent. | 應用領域 | 化工,生物產(chǎn)業(yè),農(nóng)林牧漁,制藥/生物制藥,綜合 |
Acipimox 51037-30-0
| 產(chǎn)品描述 | |
| 描述 | Acipimox is a niacin derivative used as a hypolipidemic agent. It is used in low doses and may have less marked adverse effects, although it is unclear whether the recommended dose is as effective as are standard doses of nicotinic acid. Acipimox inhibits the production of triglycerides by the liver and the secretion of VLDL, which leads indirectly to a modest reduction in LDL and increase in HDL. Long-term administration is associated with reduced mortality, but unwanted effects limit its clinical use. |
| 純度 | 99% |
| 儲存/保存方法 | Store at -20℃ for one year(Powder);Store at 2-4℃ for two weeks;Store at -20℃ for six months after dissolution. |
| 基本信息 | |
| 別名 | 阿西莫司;K-9321 |
| 外觀 | 白色或類白色粉末 |
| 可溶性/溶解性 | DMSO : 15.4 mg/mL (100 mM) water : 15.4 mg/mL (100 mM) |
| 參考文獻 | |
| 參考文獻 |
|
| 研究領域 | |
| 研究領域 | Drug DiscoverySmall Molecule DrugLead Compound Discovery |
產(chǎn)品咨詢
